ORGANISED BY:
UNDER THE AUSPICES OF
SUPPORTED BY
PROMOTING
UNDER THE AUSPICES OF
SUPPORTED BY
PROMOTING
The Lancet Oncology/Clinical Oncological Society of Australia Plenary Session |
||
| Can we improve informed consent? An international randomised controlled trial of consultation skills training | ||
| Phyllis BUTOW (Australia) | ||
| Presentation slides | ||
| The prognostic importance of p16INK4A and HPV in patients with oropharyngeal cancer treated with concurrent chemoradiation on TROG 02.02 phase III trial. | ||
| Danny RISCHIN (Australia) | ||
| Presentation slides | ||
| Interim analysis of the APML4 trial incorporating all-trans retinoic acid (ATRA), idarubicin, and intravenous arsenic trioxide (ATO) as initial therapy in acute promyelocytic leukaemia (APL): An Australasian Leukaemia and Lymphoma Group (ALLG) study. | ||
| Harry ILAND (Australia) | ||
| Presentation slides | ||
| GOFURTGO trial – an AGITG multicentre phase II study of fixed dose rate gemcitabine-oxaliplatin (Gem-Ox) integrated with concomitant 5FU and 3-D conformal radiotherapy (5FU-3DRT) for the treatment of locally advanced pancreatic cancer (LAPC). | ||
| David GOLDSTEIN (Australia) | ||
| Presentation slides | ||
| Early results of a randomised trial comparing surgery alone with surgery plus post-operative radiation therapy following resection of melanoma involving regional lymph nodes – results of the TROG 02.01/ANZMTG 01.02 Intergroup Trial. | ||
| Bryan BURMEISTER (Australia) | ||
| Presentation slides | ||
Gastrointestinal Cancer |
||
| Note: Presentations from symposium 3 were omitted because permission for online publishing were not granted by the speakers | ||
| Symposium 4 - Colorectal Cancer | ||
| CRC - Differences between East and West | ||
| WU Ming Shiang (Taiwan) | ||
| Presentation slides | ||
| Is (neo)adjuvant therapy necessary in T3 rectal cancer? | ||
| A surgeon’s view – KOH Poh Koon (Singapore) | A medical oncologist’s view – Ian CHAU (UK) | |
| Presentation slides | Presentation slides | |
| Systemic treatment of CRC | ||
| Ian CHAU (UK) | ||
| Presentation slides | ||
| Note: One of the presentations was omitted because permission for online publishing was not granted by the speaker | ||
Genitourinary Cancer |
||
| Symposium 3 - Prostate Cancer II | ||
| Optimal treatment of hormone-sensitive prostate cancer: Have we max'ed out? | ||
| Michael CARDUCCI (USA) | ||
| Presentation slides | ||
| Hormone-resistant prostate cancer: Have we made any progress since docetaxel? | ||
| Michael CARDUCCI (USA) | ||
| Presentation slides | ||
| Symposium 4 - Renal Cell Carcinoma | ||
| RCC and the art of prognostication | ||
| YE Ding-Wei (China) | ||
| Presentation slides | ||
| RCC – the Asian anti-angiogenic experience | ||
| Sun Young RHA (South Korea) | ||
| Presentation slides | ||
| Systemic management of non-clear renal cell cancer | ||
| TAY Miah Hiang (Singapore) | ||
| Presentation slides | ||
Thoracic Cancer |
||
| Symposium 3 - Recent Advances in Lung Cancer Research | ||
| EGFR mutation in never smoker: Impact of second-hand smoking | ||
| Byoung Chul CHO (South Korea) | ||
| Presentation slides | ||
| Novel targets and phase I/II agents in NSCLC | ||
| LIN Chia-Chi (Taiwan) | ||
| Presentation slides | ||
| Symposium 4 - Recent Advances in the Treatment of Lung Cancer | ||
| Recent improvement in the imaging of pulmonary tumours | ||
| Jin HUR (South Korea) | ||
| Presentation slides (large file, may take longer to download) | ||
| Recent improvement in the radiotherapy of pulmonary tumours | ||
| FU Xiao Long (China) | ||
| Presentation slides | ||
| Novel EGFR-TKIs | ||
| Pasi JÄNNE (USA) | ||
| Presentation slides | ||
Women's Health |
||
| Symposium 3 - Updates in the Treatment of Gynaecologic Cancers | ||
| Updates on management of endometrial cancer | ||
| Hextan NGAN (Hong Kong) | ||
| Presentation slides (large file, may take longer to download) | ||
| Updates on chemotherapy treatment of ovarian cancer | ||
| Sarikapan WILAILAK (Thailand) | ||
| Presentation slides (large file, may take longer to download) | ||
| Symposium 4 - Cervical Cancer Prevention | ||
| Primary prevention: HPV vaccine and it's future | ||
| TAY Sun Kuie (Singapore) | ||
| Presentation slides | ||
| Secondary prevention: The role of HPV testing in Asia Pacific Region | ||
| Efren DOMINGO (Philippines) | ||
| Presentation slides | ||
| Tertiary prevention: New trends in radiotherapy for cervical cancer | ||
| Wui-Jin KOH (USA) | ||
| Presentation slides | ||
Supportive and Palliative Oncology |
||
| Symposium 3 - Transiting from Curative to Palliative: Clinical Decision Making | ||
| Clinical decision making in advanced cancer | ||
| Ghauri AGGARWAL (Australia) | ||
| Presentation slides | ||
| Note: One of the presentations was omitted because permission for online publishing was not granted by the speaker | ||
| Symposium 4 - Transiting from Curative to Palliative: Talking about DNR | ||
| Principles of communication | ||
| Cynthia GOH (Singapore) | ||
| Presentation slides | ||
| Note: Two of the presentations were omitted because permission for online publishing was not granted by the speaker | ||
Neuro-Oncology |
||
| Genetic basis of glioma and potential for personalised medicine | ||
| Michael WELLER (Switzerland) | ||
| Presentation slides | ||
| New treatment regimens in the pipeline: an overview of current trials in treatment of glioblastoma | ||
| Wolfgang WICK (Germany) | ||
| Presentation slides | ||
Skin Cancer |
||
| Molecular vulnerabilities of melanoma | ||
| Richard KEFFORD (Australia) | ||
| Abstract | ||
| Treatment of melanoma: state of the art | ||
| Claus GARBE (Germany) | ||
| Presentation slides | ||
